Literature DB >> 11081862

Identification of prognostic factors determining risk groups for lung resection.

A Bernard1, L Ferrand, O Hagry, L Benoit, N Cheynel, J P Favre.   

Abstract

BACKGROUND: Pulmonary resection belongs to a group of surgical procedures with significant morbidity and mortality. The aims of this study were to classify postoperative complications and to identify prognostic factors determining risk group.
METHODS: In a prospective study 500 patients undergoing lung resection (wedge resection, n = 141; lobectomies, n = 245; bilobectomies, n = 12; and pneumonectomies, n = 102) were included. In 178 patients (36%) pulmonary resections were extended to structures or thoracic organs. Sleeve resection of the bronchus to preserve lung parenchyma was performed in 22 patients.
RESULTS: Classification of postoperative complications fell into four categories: patients without postoperative complications; patients with moderate complications (n = 137); patients with severe complications (n = 38); and death (n = 33). Factors adversely affecting postoperative complications by multivariate analysis included pulmonary pathology, bronchoplastic technique, forced expiratory volume in 1 second (FEV1), extended resection, type of lung resection, comorbidity indices, and preoperative chemotherapy. Four risk groups were determined. Risk group I (n = 60) with the best prognosis included patients with FEV1 greater than or equal to 80% undergoing wedge resection for a benign lesion or metastasis. Risk group II (n = 161) included patients with FEV1 greater than or equal to 80% undergoing major pulmonary resection for a benign lesion or metastasis or lung cancer, or patients with FEV1 less than 80% undergoing wedge resection for benign lesion or metastasis. Risk group III (n = 233) with a fair prognosis included patients with comorbidity indices less than 4 and FEV1 greater than or equal to 80% undergoing extended pulmonary resection for a benign lesion or metastasis or lung cancer, or patients with FEV1 less than 80% and emphysema. Risk group IV (n = 46) with the worst prognosis included patients with FEV1 less than 80% undergoing an extended lung resection or bronchoplastic procedures for a benign lesion or metastasis or lung cancer, or patients with comorbidity indices greater than or equal to 4 undergoing extended lung resection for lung cancer.
CONCLUSIONS: In a prospective study, based on these prognostic factors, a practical, easy-to-use risk group system of lung resection is proposed as a tool to aid the decision to perform lung resection.

Entities:  

Mesh:

Year:  2000        PMID: 11081862     DOI: 10.1016/s0003-4975(00)01853-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

1.  Effect of gender on perioperative outcomes after robotic-assisted pulmonary lobectomy.

Authors:  Jessica R Glover; Frank O Velez-Cubian; Wei Wei Zhang; Kavian Toosi; Tawee Tanvetyanon; Emily P Ng; Carla C Moodie; Joseph R Garrett; Jacques P Fontaine; Eric M Toloza
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Bronchial colonization and complications after lung cancer surgery.

Authors:  Jelmer E Oor; Johannes M A Daniels; Yvette J Debets-Ossenkopp; Elly S M de Lange-de Klerk; Jan W A Oosterhuis; Chris Dickhoff; Koen J Hartemink
Journal:  Langenbecks Arch Surg       Date:  2016-08-02       Impact factor: 3.445

3.  Airway bacterial colonization in patients with non-small cell lung cancer and the alterations during the perioperative period.

Authors:  Jiandong Mei; Lunxu Liu; Menglin Tang; Ninghui Xu; Qiang Pu; Chengwu Liu; Lin Ma; Hui Shi; Guowei Che
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

4.  Pneumonectomy for non-small cell lung cancer.

Authors:  Yoshinobu Ichiki; Akira Nagashima; Yasuhiro Chikaishi; Manabu Yasuda
Journal:  Surg Today       Date:  2012-04-07       Impact factor: 2.549

5.  Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude.

Authors:  Trond-Eirik Strand; Hans Rostad; Ronald A M Damhuis; Jarle Norstein
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

6.  Survival in the elderly after pneumonectomy for early-stage non-small cell lung cancer: a comparison with nonoperative management.

Authors:  Paul J Speicher; Asvin M Ganapathi; Brian R Englum; Mark W Onaitis; Thomas A D'Amico; Mark F Berry
Journal:  J Am Coll Surg       Date:  2013-12-12       Impact factor: 6.113

7.  Pulmonary angioplastic procedure for lung cancer surgery.

Authors:  Motohiro Yamashita; Eisaku Komori; Shigeki Sawada; Hiroshi Suehisa; Isao Nozaki; Akira Kurita; Shigemitsu Takashima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-01-09

8.  The impact of decreasing cutoff values for maximal oxygen consumption (VO(2)max) in the decision-making process for candidates to lung cancer surgery.

Authors:  Gaetano Rocco; Tindaro Gatani; Massimo Di Maio; Ilernando Meoli; Antonello La Rocca; Nicola Martucci; Carmine La Manna; Francesco Stefanelli
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

Review 9.  [Fast track in thoracic surgery].

Authors:  B Mühling; K H Orend; L Sunder-Plassmann
Journal:  Chirurg       Date:  2009-08       Impact factor: 0.955

10.  Glutathione S-transferase M1 gene polymorphism is related to COPD in patients with non-small-cell lung cancer.

Authors:  Ruzena Tkácová; Ján Salagovic; Marianna Ceripková; Ivan Tkác; Ján Stubna; Ivan Kalina
Journal:  Wien Klin Wochenschr       Date:  2004-02-28       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.